ArticleActa pharmaceutica Sinica. B2022

Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism.

Haiming Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.